Results 41 to 50 of about 10,367 (158)

Nonoperative urinary diversion for malignant ureteral obstruction [PDF]

open access: yesCancer, 1987
The management of malignant ureteral obstruction (MUO) has undergone major changes due to the availability of percutaneous drainage techniques and new ureteral stents for endoscopic insertion. These procedures are less morbid than conventional surgical techniques so that the indications for urinary diversion due to untreated or relapsing malignancy ...
J A, Zadra   +6 more
openaire   +2 more sources

The role of percutaneous nephrostomy in malignant ureteric obstruction [PDF]

open access: yesAnnals of The Royal College of Surgeons of England, 2005
Uraemia as a result of malignant ureteric obstruction is a recognised event in those with advanced malignancy, usually of pelvic origin, which, if left untreated, is quickly a terminal event. Palliative decompression of the obstructed urinary system, either by percutaneous nephrostomy (PCN), ureteric stent or a combination of both is a recognised ...
J R, Wilson, G H, Urwin, M J, Stower
openaire   +2 more sources

A misplacement of a ureteral stent into the abdominal aorta: a case report of a rare retrograde ureteral stenting complication

open access: yesBMC Women's Health, 2022
Background Cervical cancer is often associated with malignant ureteral obstruction and consequent hydronephrosis. Hydronephrosis caused in this way can be resolved by placing ureteral stents or performing a percutaneous nephrostomy.
Nebojsa Prijovic   +5 more
doaj   +1 more source

The efficacy and safety of ureteral dilation and long-term type ureteral stent for patients with ureteral obstruction

open access: yesUrological Science, 2015
Objective: This study was conducted to investigate the efficacy and safety of ureteral dilation and placement of a long-term ureteral stent for patients with various types of ureteral obstructions.
Ming-Hong Kao, Chung-Cheng Wang
doaj   +1 more source

Thin Needle Biopsy in the Diagnosis of Ureteral Obstruction with Malignancy [PDF]

open access: yesObstetrical & Gynecological Survey, 1978
Ureteral obstruction after treatment for abdominal cancers is a common situation in which the thin needle biopsy presents an attractive low morbidity alternative to laparotomy for the diagnosis of malignant disease. A negative biopsy is still nonconclusive, although helpful in determining the next step in the patient's management.
D B, Freiman   +4 more
openaire   +2 more sources

Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the Literature

open access: yesSociété Internationale d’Urologie Journal, 2023
BackgroundMalignant ureteral obstruction (MUO) is a common presentation in advanced urological and non-urological malignancies. Percutaneous nephrostomy (PCN) and retrograde ureteral stent (RUS) are the most commonly performed procedures to ...
Walid Eshumani   +2 more
doaj   +1 more source

Recent Advances in Ureteral Stents

open access: yes대한영상의학회지, 2019
A ureteral stent is widely used to drain ureteral obstructions, which allows urine to bypass the obstruction. The double J stent, a representative ureteral stent, has undergone many advancements in material and design recently.
Chan Park, Ji Hoon Shin
doaj   +1 more source

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

open access: yesAngewandte Chemie, Volume 138, Issue 45, 2 November 2026.
Strategic incorporation of unnatural amino acids transforms macrocyclic peptides into drug‐like molecules capable of engaging challenging targets. These building blocks enhance stability, permeability, and bioavailability, accelerating the development of next‐generation peptide therapeutics.
Krishna K. Sharma   +5 more
wiley   +2 more sources

Use of percutaneous nephrostomy in malignant ureteric obstruction

open access: yesThe British Journal of Radiology, 1991
Abstract Seventeen patients with malignant disease underwent percutaneous nephrostomy to relieve renal failure secondary to ureteric obstruction. Renal function improved in 88%. The median survival time was 18 weeks and 58% left the primary hospital to return home or to a terminal care hospice. Minor complications occurred in 58%.
M E, Chapman, J H, Reid
openaire   +2 more sources

Nephrostomy tube versus double J ureteral stent in patients with malignant ureteric obstruction. A systematic review and meta-analysis of comparative studies

open access: yesInternational Brazilian Journal of Urology, 2022
Purpose: We aimed to perform a systematic review to assess perioperative outcomes, complications, and survival in studies comparing ureteral stent and percutaneous nephrostomy in malignant ureteral obstruction.
Vineet Gauhar   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy